Tolerance and Effect on Intraocular Pressure After Administration of SYL040012

NCT00990743 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Hypertension
Glaucoma

Interventions

DRUG: SYL040012

Sponsor

Sylentis, S.A.